The study in the treatment of chronic allograft nephrophathy

范昱,谭建明,包尔敦,邱建新,唐孝达

DOI: https://doi.org/10.3969/j.issn.1001-1420.2004.11.009

2004-01-01

Journal of Clinical Urology

Abstract:Objective:To investigate effective therapeutic measure for chronic allograft nephrophathy(CAN).Methods:Patients suffered from CAN were divided into four groups according to their different therapies. 57 cases whose immunosuppressants were added up or changed belonged to the first group; the second group included 92 cases who adopted the comprehensive measures; there were 64 cases in the third group,their MMF was added up to 1.5 ～ 2.0g/d and injected Chinese medicines, Astragalus Root(Huangqi) and Red Sage Root(Danshen), at the same time; the fourth group consisted of 21 cases, the medication of prostatin was used on the basis of the therapy in the third group. The therapeutic effect of different groups were comparative studied and analysed.Results:The mean rate of efficiency in 234 cases was 34.2%, The effective power of four groups were 19.3%, 32.6%, 46.9% and 42.9%, respectively. There was a significant difference between the first group and the third group.Conclusions:The mechanism of CAN were different from the different immunosuppressive therapies; the treatment should be comprehensive based on the patients' conditions. Traditional Chinese medicines in combination with immunosuppressive drugs can improve the therapeutic effect.